Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch Deutsch
CORDIS - Forschungsergebnisse der EU
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Immunological incompatibility as a basis for cancer curing and vaccination

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Final report on Communication Activities (öffnet in neuem Fenster)

The report will provide a description of the implementation of the ULISES communication strategy, channels, formats, materials and the analysis of the generated impacts in terms of outreach and engagement.

Functionally tested pDNAs (öffnet in neuem Fenster)

Validation of the generated plasmids. Expression analysis and cellular response.

First set of potentially useful monoclonal anti-HLA-A antibodies (öffnet in neuem Fenster)

Description of a first set of potentially useful monoclonal antiHLAA antibodies capable of reacting against the alloHLA antigens expressed on the surface of tumour cells

In vitro testing of NPs in relevant cellular models (öffnet in neuem Fenster)

The final NPs (and control NPs) will be tested in relevant cellular models and tested in tumour organoids. The final NPs will be ready to be used in in vivo models in WP5.

Synthesis and characterization of NPs (öffnet in neuem Fenster)

NPs will be prepared following solgel routes and fully characterized using different techniques including electron microscopy powder xray diffraction porosimetry etc

Report on establishment of optimal collection, processing, storing and analysis of biological materials from patients (öffnet in neuem Fenster)

A report explaining the establishment of optimal collection processing storing and analysis of biological materials from pancreatic cancer patients

In vitro validation of the ULISES strategy (öffnet in neuem Fenster)

Validation of the cancer cells modification by targeted nanoparticles with the designed cargos.

In vivo validation of the ULISES strategy (öffnet in neuem Fenster)

Validation of pancreatic tumors modification by targeted nanoparticles with the designed cargos and evaluation of the therapeutic effect.

Production of transfection grade plasmid DNA (pDNA) to be used in T3.4 (assessment of pDNA effect in target cells) (öffnet in neuem Fenster)

Required amounts of pDNA will be produced following standard internal procedures

Constitution of the different management committees (öffnet in neuem Fenster)

The following committees will be formally constituted1 Project Management and Steering Committee PMSC 2 Scientific and Technical Committee STC3 Innovation and Exploitation Committee IXC4 Ethics Management Committee EMC

Web site social media and logo (öffnet in neuem Fenster)

Launch of the project visual identity logo and other grapic elements the project website and social media channels Twitter account and LinkedIn page

Communication materials (öffnet in neuem Fenster)

Communication materials will include the project flyer a short presentation video an official power point presentation of the project a rollup poster

Data Management Plan (öffnet in neuem Fenster)

The Data Management Plan will provide the protocols to be followed in the management and treatment of data

Data Management Plan, final (öffnet in neuem Fenster)

The Data Management Plan will be updated.

Veröffentlichungen

A minimal miR-142T-transgene design detargets expression from myeloid cells in the absence of a sponge effect

Autoren: Marta Parés, Aleix Angrill, Victor Pallaruelo-Santamaría, Cristina Fillat
Veröffentlicht in: 2025
Herausgeber: manuscript in preparation

Evaluation of the efficacy of a monoclonal antibody for the treatment of pancreatic cancer by complement-dependent cytotoxicity

Autoren: Ceballos-Francisco D., Ruiz Lorente I., Gimeno L., Martinez-Sanchez M.V., Parés Casellas M., Heidt S., Class F., Niemann M., Spierings E. Pallaruelo -Santamaria V., Fillat C, Minguela A
Veröffentlicht in: 2024
Herausgeber: 7th European Congress of Immunology

Development of lipid nanoparticles loaded with nucleic acids for reprogramming cancer cells and restore immune-mediated cell death

Autoren: Vicente Candela-Noguera, Javier Martínez-Latorre, Marta Parés, Alba García-Fernández, Elena Aznar, Cristina Fillat, Ramón Martínez-Máñez
Veröffentlicht in: 6th International Caparica Symposium on Nanoparticles/Nanomaterials and Applications 2024. Lisboa, 2024, ISBN 978-989-35197-2-1
Herausgeber: Printed by: PROTEOMASS Scientific Society

Development of lipid nanoparticles loaded with nucleic acids for reprogramming cancer cells and restore immune-mediated cell death

Autoren: Vicente Candela-Noguera, Javier Martínez-Latorre, Marta Parés, Alba García-Fernández, Elena Aznar, Cristina Fillat, Ramón Martínez-Máñez
Veröffentlicht in: XVI International Workshop on Sensors and Molecular Recognition. Valencia., 2023, ISBN 978-84-09-55991-6
Herausgeber: Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico

Anti-CD47 multifunctionalized lipid nanoparticles target pancreatic cancer cells and promote macrophage phagocytosis.

Autoren: Vicente Candela-Noguera, Marta Parés, Javier Martínez-Latorre, Alba García-Fernández, Elena Aznar, Victor Pallaruelo-Santamaría, Cristina Fillat, Ramón Martínez-Máñez
Veröffentlicht in: 2025
Herausgeber: (manuscript in preparation)

T-Cell Epitopes Shared Between Immunizing HLA and Donor HLA Associate With Graft Failure After Kidney Transplantation (öffnet in neuem Fenster)

Autoren: Emma T. M. Peereboom, Benedict M. Matern, Toshihide Tomosugi, Matthias Niemann, Julia Drylewicz, Irma Joosten, Wil A. Allebes, Arnold van der Meer, Luuk B. Hilbrands, Marije C. Baas, Franka E. van Reekum, Marianne C. Verhaar, Elena G. Kamburova, Marc A. J. Seelen, Jan Stephan Sanders, Bouke G. Hepkema, Annechien J. Lambeck, Laura B. Bungener, Caroline Roozendaal, Marcel G. J. Tilanus, Christien E.
Veröffentlicht in: Frontiers in Immunology, Ausgabe 12, 2023, ISSN 1664-3224
Herausgeber: Frontiers in Inmunology
DOI: 10.3389/fimmu.2021.784040

Peptides Derived From Mismatched Paternal Human Leukocyte Antigen Predicted to Be Presented by HLA-DRB1, -DRB3/4/5, -DQ, and -DP Induce Child-Specific Antibodies in Pregnant Women (öffnet in neuem Fenster)

Autoren: Matthias Niemann, Benedict M. Matern, Eric Spierings, Stefan Schaub, Gideon Hönger
Veröffentlicht in: Frontiers in Immunology, Ausgabe 12, 2021, ISSN 1664-3224
Herausgeber: Frontiers in Immunology
DOI: 10.3389/fimmu.2021.797360

A transcriptomic approach to explore the immune landscape of patient with pancreatic ductal adenocarcinoma with prognostic impact. (öffnet in neuem Fenster)

Autoren: Jose Antonio Lopez Guerrero, Marcos Melián-Sosa, Zoraida Andreu Martínez, Raquel López-Reig, Antonio Fernández-Serra, Isidro Machado, Ricardo Yaya-Tur, María García-Flores, Marta Trallero-Anoro, Carmen Martínez-Lapiedra, Fernando Martínez de Juan, Marta Ramírez-Calvo, Tania Mazcuñan-Vitiello, Patricia Carretero-Hinojosa, Rafael Estevan
Veröffentlicht in: Journal of Clinical Oncology, Ausgabe 42, 2024, Seite(n) 681-681, ISSN 0732-183X
Herausgeber: American Society of Clinical Oncology
DOI: 10.1200/jco.2024.42.3_suppl.681

A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic Microenvironments (öffnet in neuem Fenster)

Autoren: Irene Pérez-Díez, Zoraida Andreu Marta R Hidalgo, Carla Perpiñá-Clérigues, Lucía Fantín, Antonio Fernandez-Serra, María de la Iglesia-Vaya, José A Lopez-Guerrero, Francisco García-García
Veröffentlicht in: Cancers (Basel), Ausgabe 2023 May 24;15(11):2887, 2023, ISSN 2072-6694
Herausgeber: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers15112887

Suche nach OpenAIRE-Daten ...

Bei der Suche nach OpenAIRE-Daten ist ein Fehler aufgetreten

Es liegen keine Ergebnisse vor

OSZAR »